Dennis Ruff is a Primary Care physician. OpenAlex indexes 21 publications with 492 citations (h-index 11); ClinicalTrials.gov lists 8 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingClinical trials
- A Safety and Tolerability Study of RJX Drug Product in Healthy Participants
Sponsor: Reven Pharmaceuticals, Inc.
- Study to Evaluate Safety and PK of NTM-1634 vs Placebo Administered Intravenously in Healthy Adults
Sponsor: Alachua Government Services, Inc.
- A PHASE I, RANDOMIZED, PLACEBO-CONTROLLED, SINGLE DOSE ESCALATION STUDY TO INVESTIGATE SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS OF SHR0534 IN HEALTHY VOLUNTEERS
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Michael Matthay, MD
University of California San Francisco
Elaine Hylek, MD
Boston University Chobanian and Avedisian School of Medicine
Wilbert Aronow, MD
Westchester Medical Center
David Mannino, MD
University of Kentucky
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”